I really value her integrity, and she has never once tried to upsell me, which I have unfortunately experienced too many times with other medical professionals
Dillon MB, Rust HL, Thompson PR, Mowen KA
Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research
W literaturze naukowej zosta szerzej opisany w 1993 roku przez zesp Predraga Sikiria (m.in
Develop highly personalized treatment plans based on age, symptoms, lab results, lifestyle, and long-term goals
